Evidence map›Paper›PMID 32664502›Full record

ReviewInternational journal of environmental research and public health2020

Venous Thromboembolism in Children: From Diagnosis to Management.

Giuseppe Lassandro, Viviana Valeria Palmieri, Valentina Palladino, Anna Amoruso, Maria Felicia Faienza, Paola Giordano

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Impact of Pharmacist-To-Dose Enoxaparin in Pediatric Patients.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Giuseppe LassandroDepartment of Biomedical Sciences and Human Oncology, Paediatric Section, University of Bari "A. Moro", 701024 Bari, Italy.
Viviana Valeria PalmieriDepartment of Biomedical Sciences and Human Oncology, Paediatric Section, University of Bari "A. Moro", 701024 Bari, Italy.ORCID 0000-0002-1967-8861
Valentina PalladinoDepartment of Biomedical Sciences and Human Oncology, Paediatric Section, University of Bari "A. Moro", 701024 Bari, Italy.
Anna AmorusoDepartment of Biomedical Sciences and Human Oncology, Paediatric Section, University of Bari "A. Moro", 701024 Bari, Italy.
Maria Felicia FaienzaDepartment of Biomedical Sciences and Human Oncology, Paediatric Section, University of Bari "A. Moro", 701024 Bari, Italy.ORCID 0000-0002-1899-8337
Paola GiordanoDepartment of Biomedical Sciences and Human Oncology, Paediatric Section, University of Bari "A. Moro", 701024 Bari, Italy.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous thromboembolism (VTE) in children is a rare occurrence, although in recent decades we have seen an increase due to several factors, such as the rise in survival of subjects with chronic conditions, the use of catheters, and the increased sensitivity of diagnostic tools. Besides inherited thrombophilia, acquired conditions such as cardiovascular diseases, infections, chronic disorders, obesity and malignancy are also common risk factors for paediatric VTE. The treatment of paediatric VTE consists of the use of heparins and/or vitamin K antagonists to prevent dissemination, embolization, and secondary VTE. Randomized clinical trials of direct oral anticoagulants in paediatric VTE are ongoing, with the aim to improve the compliance and the care of patients. We reviewed the physiological and pathological mechanisms underlying paediatric thrombosis and updated the current diagnosis and treatment options.

Indexed as

AnticoagulantsChildHeparinHumansNeoplasmsRandomized Controlled Trials as TopicRisk FactorsThrombophiliaVenous ThromboembolismVitamin KAnticoagulantsHeparinVitamin Kdiagnosispaediatricsrisk factorsthrombosistreatment

Identifiers

PMID32664502
PMCPMC7400059
OpenAlexW3041527680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.